Surplus Solutions opens Livermore site for Sangamo lab equipment auctions

Surplus Solutions has opened a new Livermore, California facility and will auction lab and cGMP manufacturing equipment from Sangamo Therapeutics this fall. The sales are designed to keep high-value life sciences assets in circulation as West Coast buyers look for faster access to specialized gear.

Why it matters: - The Livermore site gives Surplus Solutions a larger West Coast foothold for warehousing, refurbishment, service, and auction staging. - The Sangamo asset sale puts specialized cell and gene therapy equipment back on the market after a Chapter 11 process. - Buyers in California life sciences can bid on equipment that would otherwise take months or years to source new.

What happened: - Surplus Solutions announced the opening of a new facility in Livermore, California, to support the West Coast life sciences market. - The company acquired laboratory and cGMP manufacturing equipment from the estate of Sangamo Therapeutics, Inc. - Two timed online auctions are scheduled for this fall. - Sangamo Therapeutics filed for Chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware on June 23, 2026, under Case No. 26-10989 (CTG). - Sale orders covering the equipment were entered on August 20, 2026, after a court-supervised process held August 10–11, 2026. - Auction One covers state-of-the-art R&D laboratory equipment and runs from September 14 to September 16, 2026. - Auction Two covers state-of-the-art cGMP manufacturing and laboratory equipment and runs from October 5 to October 8, 2026.

The details: - The equipment covers the development path of a cell and gene therapy program, including analytical chemistry, biophysical characterization, protein purification, flow cytometry, and single-use bioprocessing at clinical scale. - Surplus Solutions split the offering into two auctions so buyers can target assets tied to their workflows. - Auction One opens Monday, Sept. 14, 2026, at 9:00 a.m. EDT and closes Wednesday, Sept. 16, 2026, at 12:00 p.m. EDT, with some lots closing Sept. 15. - Auction One assets are offered from the Surplus Solutions facility in Livermore, California. - Pickup for Auction One is scheduled for Sept. 21 through Oct. 2, 2026. - Auction Two opens Monday, Oct. 5, 2026, at 9:00 a.m. EDT and closes Thursday, Oct. 8, 2026, at 12:00 p.m. EDT. - Auction Two assets are being offered from Sangamo Therapeutics' original site in Brisbane, California, where the equipment remains installed in the laboratory and manufacturing suites where it was in service. - Surplus Solutions said the California footprint includes Livermore and Murrieta facilities, with Livermore serving the San Francisco Bay Area and Northern California. - The 40,000-square-foot Livermore site handles warehousing, refurbishment, instrument service, decommissioning, rigging, logistics, and auction staging. - The Murrieta facility serves Southern California, including San Diego, Orange, Los Angeles, and Riverside counties.

Between the lines: - The sale reflects a growing secondary market for high-end biopharma equipment as companies restructure or exit assets. - Keeping the equipment in California could speed access for regional life sciences firms and reduce relocation friction. - Mike Ferrigno, vice president of Surplus Solutions, said the equipment is the kind typically planned and ordered months or years in advance and called the offering a rare chance to buy a complete cell and gene therapy suite available now. - Ferrigno also said the company has global distribution capability but wants much of the equipment to stay within the California life sciences ecosystem.

What's next: - Final published catalogs will determine the complete inventory in the October auction. - Interested buyers will need to watch the timed online bidding windows and the pickup schedule for the September sale. - Surplus Solutions will continue using Livermore as a West Coast hub for life sciences equipment handling and auction support.

The bottom line: - Surplus Solutions is turning a distressed biopharma equipment sale into a regional supply opportunity for California labs and manufacturers. - The new Livermore site is central to that push, giving buyers local access to high-demand tools and giving equipment a faster path back into use.